Oncology Institute (DFPH) Invested Capital (2020 - 2025)
Historic Invested Capital for Oncology Institute (DFPH) over the last 6 years, with Q3 2025 value amounting to $63.9 million.
- Oncology Institute's Invested Capital fell 4027.14% to $63.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $63.9 million, marking a year-over-year decrease of 4027.14%. This contributed to the annual value of $96.7 million for FY2024, which is 3276.38% down from last year.
- Latest data reveals that Oncology Institute reported Invested Capital of $63.9 million as of Q3 2025, which was down 4027.14% from $66.0 million recorded in Q2 2025.
- In the past 5 years, Oncology Institute's Invested Capital ranged from a high of $207.0 million in Q3 2022 and a low of $47.1 million during Q1 2021
- In the last 5 years, Oncology Institute's Invested Capital had a median value of $119.2 million in 2024 and averaged $117.2 million.
- Its Invested Capital has fluctuated over the past 5 years, first soared by 38621.83% in 2021, then tumbled by 4457.85% in 2025.
- Over the past 5 years, Oncology Institute's Invested Capital (Quarter) stood at $104.2 million in 2021, then skyrocketed by 95.66% to $203.8 million in 2022, then decreased by 29.41% to $143.9 million in 2023, then plummeted by 32.76% to $96.7 million in 2024, then crashed by 33.91% to $63.9 million in 2025.
- Its last three reported values are $63.9 million in Q3 2025, $66.0 million for Q2 2025, and $79.0 million during Q1 2025.